Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.1 HKD | -0.55% | +1.11% | -11.65% |
Mar. 26 | Mega Genomics Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 12 | Mega Genomics Stockholders to Vote March 1 on Continuing Transactions | MT |
Sales 2021 | 237M 32.73M 256M | Sales 2022 | 146M 20.11M 157M | Capitalization | 2.75B 379M 2.97B |
---|---|---|---|---|---|
Net income 2021 | 79M 10.9M 85.35M | Net income 2022 | -17M -2.35M -18.37M | EV / Sales 2021 * | - |
Net cash position 2021 | 451M 62.25M 487M | Net cash position 2022 | 398M 54.86M 429M | EV / Sales 2022 | 16.1 x |
P/E ratio 2021 * |
-
| P/E ratio 2022 |
-128
x | Employees | 229 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 51.86% |
1 day | -0.55% | ||
1 week | +1.11% | ||
Current month | -9.18% | ||
1 month | +1.11% | ||
3 months | +0.66% | ||
6 months | +16.67% | ||
Current year | -11.65% |
Managers | Title | Age | Since |
---|---|---|---|
Jing Jiang
CEO | Chief Executive Officer | 44 | - |
Xiang Yi
CTO | Chief Tech/Sci/R&D Officer | 44 | - |
Xia An
COO | Chief Operating Officer | 41 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Rong Yu
FOU | Founder | 52 | 21-04-21 |
Mei Ling Guo
BRD | Director/Board Member | 54 | 21-08-05 |
Lin Lin
CHM | Chairman | 48 | 21-04-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 9.1 | -0.55% | 4,000 |
24-04-25 | 9.15 | -0.22% | 12,400 |
24-04-24 | 9.17 | +1.33% | 70,800 |
24-04-23 | 9.05 | +1.00% | 122,400 |
24-04-22 | 8.96 | -0.99% | 20,200 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 04:08 am EDT
More quotesChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.65% | 277M | |
-17.89% | 8.36B | |
+39.20% | 3.6B | |
-39.11% | 2.73B | |
-8.06% | 2.47B | |
-7.35% | 2.32B | |
-12.61% | 1.77B | |
-19.01% | 1.55B | |
-40.66% | 1.22B | |
+7.56% | 1.09B |
- Stock Market
- Equities
- 6667 Stock